Related Experiment Video
Updated: Jun 18, 2025
07:34
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
11.6K
Nonimmune Hydrops Fetalis
Shannon B Dunn1, Julie R Whittington2,3
1Division of Neonatology, Orlando Health Winnie Palmer Hospital for Women and Babies, Orlando, FL.
Neoreviews
|July 31, 2024
Summary
Nonimmune hydrops fetalis (NIHF) is a serious condition with varied causes and high mortality. This review covers NIHF diagnosis, management, and outcomes, highlighting challenges in improving infant survival.
Area of Science:
- Perinatal Medicine
- Fetal Medicine
- Neonatology
Background:
- Nonimmune hydrops fetalis (NIHF) presents significant challenges in perinatal care.
- High mortality rates are associated with NIHF, necessitating comprehensive understanding.
- Diverse and complex etiologies contribute to the development of NIHF.
Purpose of the Study:
- To provide a comprehensive review of nonimmune hydrops fetalis (NIHF).
- To examine the pathophysiology, etiology, diagnosis, and management of NIHF.
- To discuss postnatal care, outcomes, and remaining challenges in NIHF management.
Main Methods:
- Literature review of pathophysiology, etiology, diagnosis, and management of NIHF.
- Analysis of current diagnostic techniques and their impact on identification rates.
- Examination of management strategies including termination, fetal therapy, and neonatal care.
Main Results:
- NIHF stems from various underlying pathologies, including genetic disorders, cardiovascular issues, and fetal infections.
- Advances in diagnostic techniques have improved the identification of NIHF.
- Management involves pregnancy termination for severe cases and fetal therapy for treatable conditions.
Conclusions:
- Prognosis of NIHF is influenced by gestational age at diagnosis and resuscitation needs.
- Effective neonatal care requires assessment and treatment of fluid collections and identification of underlying causes.
- Improving outcomes for infants with NIHF remains a significant challenge in perinatal medicine.
Related Concept Videos
01:19Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
01:07Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K